Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Møller

Showing results (1-10 of 546) with videos related to

Pageof 55
Sort By:
Statistics in Medicine|May 15, 1995
An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of dosesS Møller
Danish Medical Bulletin|March 21, 1998
Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosisS Møller
Ugeskrift for Laeger|April 27, 1987
[The status of psychotherapy in the curricula of psychiatry I courses in Eastern Denmark 1986]S Møller-Madsen
Sygeplejersken|February 14, 1979
[Psychological reactions of parents of children with leukemia]B S Møller
Digestive Diseases (Basel, Switzerland)|January 1, 1992
Insulin-like growth factor 1 and growth hormone in chronic liver diseaseS Møller, U Becker
Ugeskrift for Laeger|August 5, 1985
[Susceptibility of uropathogenic bacteria to mecillinam, ampicillin and a combination of mecillinam and ampicillin]E Togsverd, S Møller
Ugeskrift for Laeger|January 16, 1989
[Severe toxic hepatitis during flutamide (Eulexin) treatment]S Møller, P Iversen
Cytokine|August 18, 2006
Dietary fatty acid composition rather than vitamin E supplementation influence ex vivo cytokine and eicosanoid response of porcine alveolar macrophagesS Møller, C Lauridsen
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 1997
IGF-I in chronic liver disease: a marker of hepatocellular dysfunction, malnutrition, and survival?A Juul, S Møller
Ugeskrift for Laeger|February 21, 1998
[Decompensation]S Møller, J H Henriksen
Pageof 55

Showing results (1-10 of 546) with videos related to

Sort By:
Pageof 55
Statistics in Medicine|May 15, 1995
An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of dosesS Møller
Danish Medical Bulletin|March 21, 1998
Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosisS Møller
Ugeskrift for Laeger|April 27, 1987
[The status of psychotherapy in the curricula of psychiatry I courses in Eastern Denmark 1986]S Møller-Madsen
Sygeplejersken|February 14, 1979
[Psychological reactions of parents of children with leukemia]B S Møller
Digestive Diseases (Basel, Switzerland)|January 1, 1992
Insulin-like growth factor 1 and growth hormone in chronic liver diseaseS Møller, U Becker
Ugeskrift for Laeger|August 5, 1985
[Susceptibility of uropathogenic bacteria to mecillinam, ampicillin and a combination of mecillinam and ampicillin]E Togsverd, S Møller
Ugeskrift for Laeger|January 16, 1989
[Severe toxic hepatitis during flutamide (Eulexin) treatment]S Møller, P Iversen
Cytokine|August 18, 2006
Dietary fatty acid composition rather than vitamin E supplementation influence ex vivo cytokine and eicosanoid response of porcine alveolar macrophagesS Møller, C Lauridsen
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 1997
IGF-I in chronic liver disease: a marker of hepatocellular dysfunction, malnutrition, and survival?A Juul, S Møller
Ugeskrift for Laeger|February 21, 1998
[Decompensation]S Møller, J H Henriksen
Pageof 55